LGALS3 and lung adenocarcinoma: Kosacka et al. [27] examined the expression levels of Gal-3 and cyclin D1 in 47 NSCLC tissues and reported a negative correlation with lung adenocarcinoma, wherein they reported higher cyclin D1 expression in low Gal-3 tumors.